Lumida
/ANRO
⌘K
Alto Neuroscience Inc

Alto Neuroscience Inc

ANRO
$35.13USD-3.22%-1.17 today

MARKET CAP

1.4B

P/E (TTM)

FWD P/E

DAY RANGE

$35 – $36

52W RANGE

$3
$37

AI Summary

Stalk
Buy NowMedium

ANRO remains in a sustained Stage 2 uptrend with price testing rising 9- and 20-day EMA support after a minor pullback from 52-week highs. With EMAs aligned and momentum intact, shallow pullbacks into this zone offer attractive entries while timing remains favorable now.

  • Stock gained 9.2% over past two weeks, signaling strong momentum factors.
  • “Moderate Buy” consensus with $36.63 target implies 25.8% upside.
  • EPS expected to fall from ($3.14) to ($3.56), indicating financial strain.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICTREND
Sales, Adj.
YoY %
P / Sales
EV / Sales
Gross Profit, Adj.
YoY %
Margin %
EV / Gross Profit
EBITDA, Adj.
YoY %
Margin %
EV / EBITDA
EBIT
YoY %
Margin %
EV / EBIT
Net Income
YoY %
Net Margin
EPS (GAAP)
YoY %